Navigation Links
Hard To Treat Diseases (HTDS) in Merger Talks with Mellow Hope, China

SHENZHEN, China, Jan. 14 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS) management representatives are currently in China negotiating a merger agreement with Shenzhen Mellow Hope Pharm Industrial Co., Ltd. (Mellow Hope).

Mellow Hope is the biggest exporter of Biological Vaccines in China, and has a product line that encompasses vaccines for influenza, tetanus, diphtheria and other diseases; Blood based products including human rabies immunoglobulin; and active pharmaceutical ingredient (or APIs) for injection such as celestatin.

Mellow Hope revenues are currently in excess of $15 million USD, and growing.

Interim company CEO Keith Roberts noted "We think there are going to be strong synergies between our European division and Mellow Hope. Mellow Hope brings a substantial pharmaceutical production and testing capability to the forefront of the Company. In turn, HTDS can provide vital and meaningful assistance to Mellow Hope in developing its export business to Europe and beyond".

Based on initial negotiations, the company anticipates having a formal Letter of Intent in place within a week to ten days, and will provide additional updates on developments as they unfold.

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: Certain information contained in this release contains forward-looking statements that involve risk and uncertainties, including but not limited to, those relating to development and expansion activities, domestic and global conditions, and market competition.

CONTACT: For scientific dialogue and inquiry only Andrea can be reached via e-mail at; For any corporate matters the readers should contact the company directly at

SOURCE Hard to Treat Diseases
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Increasing Use of Ablation to Treat Atrial Fibrillation
2. Frost & Sullivan Recognizes Neotropixs Approach to the Treatment of Small Cell Lung Cancer and Neuroendocrine Cancers
3. Merck Serono and Apitope Announce Licensing Agreement on Novel Peptide Therapeutics for the Treatment of Multiple Sclerosis
4. Irishman with Peripheral Arterial Disease (P.A.D.) Finds Leg-, Life-Saving Treatment In Columbus, Ohio
5. Popular cold and cough treatment may create respiratory distress in young children
6. Photos: Arthritis Foundation Launches Nationwide Movement Encouraging People to Move to Prevent and Treat Arthritis
7. SNM praises CMS decision to expand reimbursement for cancer treatment
8. Childhood Leukemia Subtype Resists Treatment
9. Penn study: Chances of surviving cardiac arrest depend on where patients are treated
10. Rhode Island Hospital first in US to treat kidney tumor with new device using electrical pulses
11. Hard To Treat Diseases (HTDS) Recapitalization
Post Your Comments:
(Date:11/27/2015)... Raleigh, NC (PRWEB) , ... November 27, 2015 , ... ... most effective ways to treat it. Surviving Mesothelioma has just posted the findings ... Researchers at University Hospital Zurich analyzed the cases of 136 mesothelioma patients who were ...
(Date:11/27/2015)... ... November 27, 2015 , ... The print component ... Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation of ... distributed nationally, through a vast social media strategy and across a network of ...
(Date:11/27/2015)... Wilmington, DE (PRWEB) , ... November 27, 2015 ... ... a member of the well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as ... is an independent group of Microsoft Dynamics SL software users, partners, industry experts ...
(Date:11/27/2015)... Los Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... the Commission on Accreditation of Allied Health Education Programs (CAAHEP) awarded accreditation to its ... exclusive list of CAAHEP accredited colleges, as only one of twelve colleges and universities ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft Inc., ... the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite 5.10 ... brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive not ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... November 26, 2015 --> ... use SyMRI to find optimal contrast weighting of MRI ... and has signed a research agreement with SyntheticMR in order ... Using SyMRI, it is possible to generate multiple contrast images ... the patient has left, thus making it possible to both ...
(Date:11/26/2015)... DUBLIN , Nov. 26, 2015 ... the addition of the "2016 Future Horizons ... Monitoring (TDM) Market: Supplier Shares, Country Segment Forecasts, ... offering. --> ... comprehensive analysis of the Japanese therapeutic drug monitoring ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 /PRNewswire/ ... the addition of the "2016 Future ... Drugs of Abuse Testing Market: Supplier Shares, ... report to their offering. --> ... of the "2016 Future Horizons and ...
Breaking Medicine Technology: